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Jeanne Calment, who died recently in her 123d year,
being the oldest human being alive on earth, epitomized
our quest for longevity. This deeply rooted quest has
been spurred by recent strides in genetics, giving rise to
renewed hopes that answers to the puzzle of aging may
lie close at hand, in our genome. Indeed, a survey of
Jeanne Calment’s ancestry revealed a striking aggrega-
tion of the longevity trait: 24% of her 55 immediate
ancestors have lived to age 180 years, as compared to
merely 2% of an adequately paired control group (Ro-
bine and Allard 1998). Like other multifactorial traits,
longevity aggregates, rather than segregates, in families,
displaying a low heritability. Added to the stringent age
requirements for probands, this limits practicable strat-
egies for searching for underlying genetic variants in
humans.
Centenarians, as examples of extreme longevity, ap-
proaching our species’ maximum potential life span, ex-
ert a strong fascination. While differences in maximum
life spans (MLS) among species ultimately relate to their
genomes, the existence and extent of a genetic flexibility
in this potential within humans is far less obvious. Lon-
gevity is the final outcome of aging processes that affect
every level of biological organization, interacting and
integrated over a lifetime. Finch and Rose (1995) have
proposed a hierarchy of biology in five levels that aims
to understand the architecture of life history, of which
life span is but one component. The genome occupies a
central position in this hierarchy, a position that calls
for diverse viewpoints.
Genetic Polymorphism of Longevity
The seemingly fanciful hope of finding single muta-
tions that confer long life has been realized in the nem-
atode Caenorhabditis elegans. Since the initial discovery
of age-1, ∼10 different gerontogenes—genes involved in
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life prolongation—have been found (Finch and Tanzi
1997). The life extension displayed by the mutant nem-
atodes may be as much as fivefold in certain double-
mutant strains, and it stems at least in part from slower
aging. In Drosophila, protocols of selection for delayed
fertility have yielded strains with a more-than-twofold-
increased life span, but so far no individual gene effect
has been identified. Rather, it appears that heritable
shifts in MLS depend on the natural variability at hun-
dreds of polymorphic loci. In mammalian species, al-
lometric equations link MLS with brain weight and body
weight, allowing the former to be deduced from esti-
mates of the latter traits in fossil specimens. Applied to
hominid species, this approach suggests a doubling of
the MLS within the past 3 million years along the ev-
olutionary line that leads to modern man. This conclu-
sion may indicate that relatively few genes, in the range
of 40–250, are involved in controlling MLS (Cutler
1975). The spectacular recent increase in the mean lon-
gevity of human populations has not been accompanied
by an increase of MLS, which has remained stable, at
∼120 years of age, over historically recorded times. A
lasting question is whether there exists a polymorphism
of MLS in present human populations or only interin-
dividual differences in longevity. In the former case, one
might expect to find major-gene effects in centenarians,
whereas in the latter case, many genetic variants would
contribute to survival through advanced ages.
The impact of apolipoprotein E (APOE) alleles on
survival in different pathological contexts has been am-
ply confirmed (Finch and Tanzi 1997). Since causal var-
iants were identified from the outset, these epidemio-
logical data have opened new avenues for probing into
molecular mechanisms of cardiovascular and neurode-
generative diseases. Contradictory reports on the human
leukocyte antigen (HLA) locus have fueled controversy
for 12 decades. A sufficiently large number of long-lived
probands has now revealed the influence of three alleles:
HLA-DR7, DR11, and DR13 (Ivanova et al. 1998). The
first two alleles displayed interactions with sex in their
effect on survival, which is most interesting in view of
the sex-specific effects on life span of autosomal quan-
titative-trait loci (QTLs) found in Drosophila (Nuzhdin
et al. 1997). The QTLs that affect life span inDrosophila
Scha¨chter: Human Genetics ’98 1009
also had age-specific effects on mortality. This is remi-
niscent of the late-acting (10th decade) effects of HLA-
DR alleles on human survival, effects that were missed
in previous studies that applied an age cutoff of 80 or
90 years. A study of genetic hemostasis factors in Italian
centenarians reported a higher frequency of a variant of
the plasminogen activator inhibitor 1 (PAI-1) that has
been associated with elevated plasma levels of this pro-
tein as well as with heightened risk of myocardial in-
farction in adults (Mannucci et al. 1997). This finding,
like our results on the angiotensin-converting enzyme
(ACE) polymorphisms (Scha¨chter et al. 1994), provides
a genetic background to the surprising phenotype of hy-
percoagulability described in centenarians (Mari et al.
1995).
These scattered data should not obscure the fact that
association studies aimed at identifying such loci are still
in their infancy. However, the four genes so far impli-
cated in longevity, APOE, ACE, HLA-DR, and PAI-1,
share common features: (1) they have an impact on in-
termediary traits, such as plasma levels of a homeostatic
protein or immune response, and (2) they display gene-
environment interactions in normal adult populations.
These are general features of common multifactorial dis-
eases with polygenic effects and environmental com-
ponents (Sing and Reilly 1993), which should not sur-
prise us, since such diseases are leading causes of death
and thus limit life span. Hence, these genes appear to
affect longevity by modulating an individual’s responses
to life-threatening disorders, not by regulating MLS as
an intrinsic physiological trait.
Compensatory Adaptation (CA) in Survival
The “compensation effect on mortality” is one of the
more puzzling observations in human gerontology. This
term refers to the convergence property of mortalities
from various populations. Mortality increases exponen-
tially with age in any population, its dynamics being
defined by the two population-specific values of an initial
mortality rate (usually given as ∼20 years of age) and
the mortality-doubling time, which measures aging. The
observation is that mortalities converge toward a com-
mon value in the 80–90-year range; in other words, dif-
ferences in rates of increase compensate for initial dif-
ferences in mortality. This property implies that causes
of death should be correlated, which has been exten-
sively documented by Gavrilov and Gavrilova (1991).
It also explains why genetic effects are stronger on age-
related pathologies than on life span, while they may yet
be detected in centenarians.
Genetic associations with longevity are likely to reveal
hitherto unsuspected etiologic links among pathologies.
For example, considering the impact of APOE on car-
diovascular and Alzheimer diseases, it may be worth-
while to investigate its role in cancer, the third major
pathology of aging. The effect of APOE alleles on sur-
vival may be related to the changing physiological role
of serum cholesterol during aging. High cholesterol lev-
els that are a risk factor in the 40s and 50s become
beneficial in the 9th decade of life, whereas low choles-
terol levels become associated with greater cancer inci-
dence and mortality (Weverling-Rijnsburger et al. 1997).
Similarly, thymic involution in conjunction with chronic
immune challenge may lead to an expansion of certain
T-cell subsets in very aged individuals. A similar pattern
has been observed in HIV-infected patients (see Effros
1998 [in this issue]).
These age-related changes in the physiological role of
one homeostatic parameter speak of CA, defined as a
long-lasting adaptation occurring in any subsystem of
an organism in response to a shortcoming in this or
another subsystem. CA results in alterations of the values
or physiological role of a homeostatic trait; hence, CA
differs fundamentally from homeostasis, in that CA im-
plies a durable and often irreversible departure from the
state optimized by natural selection. CA therefore even-
tually leads to some loss of viability in an initially fit
organism. Looking at the complete life cycle, one may
distinguish the early portion of the phenotype, which
has been sculpted by natural selection, from the late
portion, when the organism continues to survive beyond
the realm of optimized fitness. This is when natural se-
lection pressure has decreased to nearly zero, after men-
opause for women, in the 5th decade of life for both
sexes.
At the population level, aging represents an acceler-
ation in mortality with age; this effect may be under-
stood, at the individual level, as a decline over time in
the ability to respond to external or internal perturba-
tions. An organism survives in the face of various kinds
of stress by reorganizing its physiological responses, but
it is constrained in its ability to make such adjustments,
by its resources and its patterns of homeostasis. These
homeostasic response patterns are molded by the evo-
lutionary history of the organism and are finely honed
to handle perturbations that arise in early life. The same
patterns may become harmful in later life, if they operate
in a physiological environment for which they were not
selected. These evolutionary considerations may explain
some of the apparent paradoxes encountered in studying
the very old. For example, cardiomyocytes die off pro-
gressively during aging, so that sinus-node cells, which
entrain other cardiac cells, are ∼90% depleted by the
eighth decade of life (Wei 1992). The compensatory ef-
fort in maintaining the cardiac rhythm may account for
enlargement of the remaining cells. Higher plasma levels
of ACE, which have been associated with left-ventricular
hypertrophy (Schunkert et al. 1994), may favor this ad-
aptation. The ACE D/D genotype is known to confer
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an increased risk of myocardial infarction, but it may
also favor the CA of cardiac hypertrophy: such an effect
might be evident in a study of the ACE genotype in a
group of elderly athletes trained in aerobic sports. Sim-
ilarly, the hypercoagulability in centenarians’ blood
(Mari et al. 1995) may represent an adaptation to dam-
aged vasculature, chronic inflammation, and atheroscle-
rosis (Ross 1993), but this feature is inextricably linked
with an increased danger of clotting and strokes. The
associations found in long-lived groups with HLA-DR
alleles, which are arguably the causal variants, may be
taken as clues to molecular interactions of these variants
in mediating life-limiting immune responses (Ivanova et
al. 1998). Indeed, we found a highly significant associ-
ation of the DR11 allele with rapid progression of dis-
ease in HIV-infected patients, the association being
stronger in women (F. Scha¨chter, S. Caiilat-Zucman, J.
Rappaport, and J.-F. Zagury, unpublished data).
When physiological responses cause irreversible, ul-
timately life-threatening damage in older individuals,
they shall be referred to as “CA.” CA might therefore
be defined as a trade-off between present and future
survival—which is really another way to say aging. This
concept may be helpful in allowing primary aging pro-
cesses to be disentangled from secondary changes, a last-
ing conundrum in the field of gerontology. Primary aging
processes encompass various types of irreversible struc-
tural damage, at the core of which is damage incurred
by the genome. It is expected that gene-specific and tis-
sue-specific patterns of damage will ultimately appear to
be related to changes in the alleles’ survival values during
aging. For example, if a vital gene becomes progressively
inactivated by damage, structural or regulatory variants
that favor compensatory overexpression will confer an
advantage in late survival.
CA may arise whenever homeostatic mechanisms are
inadequate to respond to various kinds of stress. A novel
strategy for finding candidate genes in longevity follows
directly from this observation: quantitative traits under
homeostatic control should be examined for interindi-
vidual variation not only in their mean value but also
in their variance. Indeed, the pattern of response to per-
turbations and its alteration by CA may be even more
relevant to aging than is the average value of the trait.
For example, serum dehydroepiandrosterone sulfate
(DHEAS) levels (1) are variable among comparable sub-
jects, (2) are stable in each subject, (3) decrease sharply
with aging, and (4) are believed to influence suscepti-
bility to multiple age-related pathologies. Therefore, it
should prove interesting to identify the genetic variants
underlying serum DHEAS variations and to look at their
distributions in long-lived groups.
Toward a Genetics of Chronobiology
Homeostatic quantitative traits are often character-
ized only by their average value and variance, but in fact
they also have a temporal structure, and this is the do-
main of “chronobiology.” Body temperature and blood
levels of various hormones, for example, are subject to
daily cyclic fluctuations. These cycles become disrupted
during aging. Examples abound of age-related distur-
bances of biological rhythms, in sleep-wake cycles, in
circadian and monthly cycles of hormone production,
etc. The major-histocompatibility-complex genotype has
been shown to influence estrous cycles, as well as fertility
and life span, in mice (Finch and Rose 1995). Whether
such genetic effects exist in women’s menstrual cycles
might be worth investigating.
Much work and attention have been devoted to the
melatonin cycle, which displays not only changes in pe-
riodicity but also decreased amplitudes in aged persons
(Reiter 1995). Still more subtle changes occur as well.
Any periodic signal may be analyzed in terms of com-
plexity, as measured by the entropy of the signal (Pincus
et al. 1991). This entropy reflects the degree of “unpre-
dictability” of the signal. It has been found to decrease
with aging, for various physiological functions, espe-
cially cardiovascular control, leading to the concept that
aging is associated with a pervasive loss of complexity
(Lipsitz and Goldberger 1992). Measures of complexity
for various biological rhythms, and the rate at which
they decline during an organism’s lifetime, may therefore
be added to the list of meaningful homeostatic traits,
qualifying as potential biomarkers of aging. Their ge-
netic determinants should be investigated. The ideal
biomarker would faithfully reflect aging, and its rate of
change would predict life span. Such biomarkers exist
in C. elegans, where life-extending mutations in the
Clock genes decrease aging by generally slowing down
the pace of living in the nematodes (Finch and Tanzi
1997). One may still wonder whether this might be pos-
sible in humans.
“Longevity Genes”: Regulating MLS or Disease
Susceptibility?
Existing evolutionary theories of aging fail to provide
a mechanism for age-related changes in the relative sur-
vival values of genetic variants; they merely state that
such changes are expected. The basic argument is that
since the force of natural selection decreases sharply after
(and even during) the reproductive period, deleterious
gene action with onset in that portion of the life cycle
is not counterselected and therefore should have accu-
mulated in the course of evolution. “Antagonistic plei-
otropy” further suggests the concept that early beneficial
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and late deleterious effects may be correlated. The dis-
posable-soma theory, meaning that the soma may be
disposed of as long as the survival of the germ line is
assured, treats the problem of resource allocation be-
tween reproduction and somatic maintenance (Kirk-
wood and Rose 1991). Under this theory, the level of
somatic maintenance depends in part on the life expec-
tancy of the species in its natural evolutionary environ-
ment. Since they view aging as the consequence of a
randomly accumulated genetic load, all of these theories
predict that the effects of aging should be manifold and
species specific. They also predict that aging and sex
should be intimately related: the former would appear
as a passive by-product of the evolution of a life-history
strategy, and life span would be constrained only to the
extent of compatibility with a reproductive schedule.
The scope of the genetic epidemiology of aging would
then be to characterize our species’ genetic load, which
limits the range of physiological states available to older
individuals.
Patterns of allele frequencies in elderly groups should
reflect these constraints. We have shown elsewhere how
the sheer mathematics of increased mortality should per-
mit the identification of allele-specific effects on survival
in advanced age groups, and how the compensation ef-
fect on mortality emerges as a general property, with a
turning point at ∼90 (Toupance et al. 1998). While pro-
viding a bridge between genetic epidemiology and a de-
mography of aging, these calculations still do not explain
how, at the individual level, a given gene becomes rel-
atively deleterious to survival. The idea of CA suggests
that the effects of longevity-associated alleles will depend
on the specific environment and history of each cohort
examined. For example, cohorts of centenarians who
lived through the great Spanish influenza epidemic at
ages of 1 or 5 years may not share the same genetic
structure. This in turn has two consequences: (1) we
should be forewarned against inadequate comparisons
between different long-lived cohorts, and (2) it is worth
investigating candidate genes in different cohorts. Mar-
tin et al. (1996) have proposed a distinction between
“private” species-specific mechanisms of aging and
“public” mechanisms that would be widely shared
across species. CA provides clues to the private set of
genes. The gradual emergence of these gene effects in
old individuals is driven by primary aging processes,
which involve the genome as a target, rather than a
determinant, of aging.
The Ambiguous Role of the Genome
Although, 2 decades ago, damage to mtDNA was pos-
tulated to occur with aging, its quantitative detection
had to await PCR and the design of specific primers.
The nakedness of the mitochondrial genome and its top-
ological exposure to reactive oxygen metabolites render
the mtDNA particularly vulnerable to damage. The most
frequent mutations involve deletions of portions of the
genome that are flanked by direct sequence repeats, but
point mutations also accumulate with aging (Wallace
1992). These accumulate in nondividing cells within tis-
sues that have high respiratory rates, such as neurons
and muscle cells, notably in cardiomyocytes. The ap-
pearance and multiplication of defective mitochondria
provides an example of detrimental CA at the cellular
level; it seems that energy demands on the cell stimulate
mitochondrial division specifically in cells that already
carry defective mitochondria, eventually leading to ov-
erproliferation of these defective mitochondria and to
loss of cell function.
Mitochondria with a defective genome lose control of
oxidative phosphorylation, which becomes uncoupled.
This produces more free radicals, which in turn increase
damage to mitochondrial and other components in the
cell, setting up a vicious cycle. The rate of oxidative
damage is proportional to the metabolic rate and in-
creases with aging (Sohal and Weindruch 1996), in ac-
cordance with the classic “rate-of-living” theory of ag-
ing, which addresses the inverse correlation between
basal metabolic rate and life span. The life-prolonging
effect of antioxidative enzymes in flies and of caloric
restriction in rodents has been interpreted in this light.
Martin et al. (1996) have reviewed data supporting the
general role of oxidative stress in aging, such as the
observation that life-extended mutants in C. elegans and
Drosophila share an increased resistance to oxidative
and other stresses. All macromolecules—DNA, RNA,
proteins, lipids—are targets of oxidative damage.
Among the most common and mutagenic by-products
of such damage are the oxidized nucleotides 8-oxo-
dGTP and 8-oxo-rGTP. In a recent report, Taddei et al.
(1997) have shown that the E. coli MutT protein, which
has mammalian homologues, is able to efficiently re-
move not only 8-oxo-dGTP but also 8-oxo-rGTP,
thereby enhancing both DNA replication and transcrip-
tion fidelity. Transcription errors may contribute to the
accumulation of modified proteins with altered enzyme
activities, independently of genomic mutations.
The nuclear genome staves off relentless attack, with
powerful and versatile systems of DNA editing. Ranking
among the classic theories of aging is the somatic mu-
tation–accumulation hypothesis. In spite of extensive ev-
idence (gathered, for the most part, 2 decades ago) on
gross chromosomal abnormalities in old cells, the data
for somatic mutation in aging are astonishingly scanty
when compared with the abundance generated in the
somatic genetics of cancer. Although there is good evi-
dence for global alterations of the genome in terminally
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senescent fibroblasts (Macieira-Coelho 1995), we still
lack specific examples of age-related genomic damage,
aside from the well-known telomere story (see Effros
1998).
From mitochondria, we have learned that we need to
focus on specific tissues and specific genes if we are to
detect and quantify age-related alterations, but we have
only begun to apply this lesson to the nuclear genome.
Tischfield (1997) recently proposed a broad definition
of loss of heterozygosity (LOH) as the loss of a func-
tional gene product encoded by a particular locus, and
he showed that mitotic recombination leads to extensive
LOH in normal human T cells and fibroblasts. This
clearly qualifies as a candidate primary mechanism of
cellular aging in vivo and in vitro. Tischfield focused,
for experimental ease, on the adenine phosphoribosyl-
transferase (APRT) locus, which maps to the subtelom-
eric region of 16q. His conclusions may be broadly ap-
plicable to other genes in autosomal subtelomeric
regions, where rates of mitotic recombination in aging
cells may be influenced by cis-acting effects of shortened
telomeres (Meltzer et al. 1993). Many other loci within
the nuclear genome are expected to undergo age-related
damage in the form of broad-sense LOH (Tischfield
1997). For example, both the hypoxanthine guanine
phosphoribosyltransferase (HPRT) gene on the X chro-
mosome and HLA-A2 in the HLA region have high so-
matic-mutation rates and are prone to age-related LOH
in dividing cells. Indeed, a linear decrease of the enzyme-
activity ratio of HPRT/APRT has been reported in aging
fibroblast cultures (Paz et al. 1981).
Qian and Germino (1997) have proposed that somatic
mutations, which sensitize a tissue to the effects of a
“second hit” at the same locus, may explain the focal
and highly variable progression of many diseases. Such
progression is also a generic feature of aging at the tissue
level. For example, the discovery, by histochemistry, of
isolated cytochrome c oxidase–negative fibers in aged
cardiac tissues was seminal in triggering the search for
mtDNA deletions. A most interesting example of age-
related local cellular alteration is the appearance of rev-
ertant neurons in the homozygous Brattleboro rat (Finch
and Goodman 1997). In these rats, the vasopressin gene
is inactivated by a single-base deletion, conferring a phe-
notype of diabetes insipidus. Heterozygosity appears
gradually and in a linear fashion with aging, only in
those neurons that are under chronic hyperosmotic stress
for the synthesis of vasopressin. The mechanism seems
to involve posttranscriptional mutations leading to phe-
notypic reversion, including hybrid mRNA molecules
with the neighboring homologous oxytocin gene. This
remarkable case of CA in individual neurons could be
generalized to other genes (Finch and Goodman 1997).
Homologous recombination provides for a certain ge-
nomic plasticity in meiosis and mitosis and even in non-
dividing cells. The expression of this plasticity is con-
trolled by genes of the mismatch-repair system (MRS)
and depends on the genomic region as well as on the
cellular context. Data are growing on the variability,
according to the region, genotype, or haplotype, of re-
combination rates within the genome (Robinson 1996).
A case in point is again the HLA region, where haplo-
types carrying the DR11 allele have the highest recom-
bination rates. Homologous recombination, as modu-
lated by the set level of the MRS, regulates both the rate
of germ-line mutations giving rise to genetic diseases and
the rate of somatic mutations. Defects in the MRS ac-
count for a diverse array of genome mutations (Radman
et al. 1995). On the other hand, adaptation requires a
degree of genomic plasticity, and the same plasticity also
serves in cellular ontogeny and differentiation. Obvi-
ously, the mutation rate that maximizes population fit-
ness depends on the environment. The discussion leads
us to the thesis that this set rate of genomic plasticity is
also a central determinant of aging and life span.
X-chromosomal loci may provide a crucial test for
models of DNA damage in aging. Since these genes are
functionally hemizygous in both males and females, ef-
fects on longevity of lesions on the X chromosome may
be relatively easy to observe. The genealogical study re-
cently published by Gavrilov et al. (1997) provides co-
gent support for the impact that aging has on the somatic
load on the X chromosome. Investigating correlations
between parental age at conception and children’s lon-
gevity, the authors reported a highly significant decrease
in the life span of daughters—but not sons—born to
elderly fathers. Their data suggest that X-chromosome
damage accumulates with age in both the male germ line
and somatic tissues and that it may limit life span. These
findings shed light on a hitherto unexplained oddity in
the familial pattern of transmission of longev-
ity—namely, the weak father-daughter correlation (Ab-
bott et al. 1974). A maternal-grandfather effect on the
longevity of males would then also be expected. A hint
to that effect may come from a study of the Duchenne
muscular dystrophy locus on Xp21, which reported that
the mean age of maternal grandfathers, at birth of the
carrier daughter, was 33.7 years, compared with a value
of 29.5 years for the general population and intrape-
digree controls (Bucher et al. 1980). Similar effects may
be sought in pedigrees segregating for X-linked pheno-
types. A more direct test of the hypothesis would be to
quantify mutations according to relevant parameters at
specific loci on the X chromosome, for which there are
already clues of increased fragility with aging.
These findings and hypotheses have important evo-
lutionary implications. Loci on the mammalian X chro-
mosome spend two-thirds of their time in oocytes rather
than in sperm cells. In addition to other mutation-re-
ducing mechanisms, this accounts for a slower mutation
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rate of these loci (McVean and Hurst 1997), which har-
bor precious genes in particularly well-conserved syn-
tenic groups (Ohno 1973). On the other hand, X-chro-
mosome loci are more sensitive to damage than are
autosomal loci in somatic cells, because they lack a part-
ner for repair by homologous recombination, and such
damage has a dominant cellular phenotype. Thus, the
X chromosome is at the same time protected in the germ
line and critically vulnerable in the soma, whereas its
rate of damage accumulation in sperm cells may limit
male reproduction. This may represent the case par ex-
cellence of trade-off between germ-line propagation and
somatic maintenance, the very exemplification of the
cost of sex in terms of aging.
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